Ulteriori informazioni
"Delivery of Drugs: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume Two examines the formulation of micro-nanosized drug delivery systems and recaps opportunities for using physical methods to improve efficacy via mechano-, electroporation. The book highlights innovative delivery methods like PIPAC, including discussions on the regulatory aspects of complex injectables. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stakeholders. This level of discussion makes it a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems"--
Sommario
1. Bioactive hybrid nanowires: a new in trend for site-speci¿c drug delivery and targeting
A.R. FERNANDES, J. DIAS-FERREIRA, M.C. TEIXEIRA, A.A.M. SHIMOJO, PATRÍCIA SEVERINO, A.M. SILVA, RANJITA SHEGOKAR, AND ELIANA B. SOUTO
2. Opportunities and challenges of 3D-printed pharmaceutical dosage forms
ADAM PROCOPIO AND DIVYA TEWARI
3. Marketing authorization and licensing of medicinal products in EU: Regulatory aspects
MUHANED AL-HINDAWI
4. Clinical considerations on micro- and nanodrug delivery systems
PRAMIL TIWARI, VIVEK RANJAN SINHA, AND RANDEEP KAUR
5. Nanoparticulate treatments for oral delivery
ROHIT C. GHAN
6. Pharmaceutical mini-tablets: a revived trend
VENKAT TUMULURI
7. Liquid crystalline drug delivery systems
LUCIANA NALONE, CONRADO MARQUES, SALVANA COSTA, ELIANA B. SOUTO, AND PATRÍCIA SEVERINO
8. Amorphous drug stabilization using mesoporous materials
DANILLO F.M.C. VELOSO, MATTHIAS M. KNOPP, AND KORBINIAN LEUROBMANN
9. "Quality? of pharmaceutical products for human usedunderlying concepts and required practices
SAEED A. QURESHI
10. Optimizing intraperitoneal drug delivery: pressurized intraperitoneal aerosol chemotherapy (PIPAC)
M.A. REYMOND AND A. KEURONIGSRAINER
11. Upscaling and GMP production of pharmaceutical drug delivery systems
NAZENDE GEURUNDAY TEURURELI AND AKIF EMRE TEURURELI
Info autore
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
